GLP-1 medications are often well suited for patients who: Experience frequent hunger or difficulty with portion control Respond well to appetite suppression alone Prefer a slower, more gradual weight loss trajectory Are sensitive to medications and benefit from a single-pathway approach While GLP-1 therapies can be highly effective, they may be less impactful for patients with significant insulin resistance or deeper metabolic dysfunction
Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC)
6mm, 8mm, 12.7mm older lengths, no longer recommended for routine self-injection
There are no published clinical trials specifically studying GLP-1 microdosing
And I'm like, "Oh, these are peptides
In the fourth quarter alone, Darzalex generated over $3 billion in sales, marking the first time a single J&J drug surpassed that threshold in a quarter, the company said